Filing Details
- Accession Number:
- 0001209191-18-034494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-31 19:03:26
- Reporting Period:
- 2018-05-31
- Accepted Time:
- 2018-05-31 19:03:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1607678 | Viking Therapeutics Inc. | VKTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1517780 | Michael Morneau | C/O Viking Therapeutics, Inc. 12340 El Camino Real, Suite 250 San Diego CA 92130 | Vp, Finance And Administration | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2018-05-31 | 21,551 | $9.25 | 94,035 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- All 21,551 of the shares were acquired on May 18, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
Billionaire Hedge Funds
